HuGE Literature Finder
Records
1
-
3
Imatinib and polypharmacy in very old patients with chronic myeloid leukemia: effects on response rate, toxicity and outcome. Oncotarget 2016 Aug . Iurlo Alessandra, Nobili Alessandro, Latagliata Roberto, Bucelli Cristina, Castagnetti Fausto, Breccia Massimo, Abruzzese Elisabetta, Cattaneo Daniele, Fava Carmen, Ferrero Dario, Gozzini Antonella, Bonifacio Massimiliano, Tiribelli Mario, Pregno Patrizia, Stagno Fabio, Vigneri Paolo, Annunziata Mario, Cavazzini Francesco, Binotto Gianni, Mansueto Giovanna, Russo Sabina, Falzetti Franca, Montefusco Enrico, Gugliotta Gabriele, Storti Sergio, D'Addosio Ada M, Scaffidi Luigi, Cortesi Laura, Cedrone Michele, Rossi Antonella Russo, Avanzini Paolo, Mauro Endri, Spadea Antonio, Celesti Francesca, Giglio Gianfranco, Isidori Alessandro, Crugnola Monica, Calistri Elisabetta, Sorà Federica, Rege-Cambrin Giovanna, Sica Simona, Luciano Luigiana, Galimberti Sara, Orlandi Ester M, Bocchia Monica, Tettamanti Mauro, Alimena Giuliana, Saglio Giuseppe, Rosti Gianantonio, Mannucci Pier Mannuccio, Cortelezzi Agosti |
Gene polymorphisms and febrile neutropenia in acute leukemia--no association with IL-4, CCR-5, IL-1RA, but the MBL-2, ACE, and TLR-4 are associated with the disease in Turkish patients: a preliminary study. Genetic testing and molecular biomarkers 2014 Jul 18 (7): 474-81. Pehlivan Mustafa, Sahin Handan Haydaro?lu, Ozdilli Kur?at, Onay Hüseyin, Ozcan Ali, Ozkinay Ferda, Pehlivan Saci |
I/D ACE gene polymorphism in survival of leukemia patients -- hypothesis and pilot study. Medical hypotheses 2003 Jul 61 (1): 80-5. Hajek Dobroslav, Tomiska Miroslav, Krahulcova Eva, Druckmuller Miloslav, Florianova Michaela, Izakovicova-Holla Lydie, Vacha Ji |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 22, 2023
- Content source: